Cards heights and widths

Cards Hyperlinks/Flip/Media/Pop up

Title

Potential new vaccines and medicines in Phase 3 and registration since 2017
23
Vaccines delivered in 2021
>767m
Medicine doses delivered in 2021
1.7bn
Major approvals since 2017
13

Home

Figures module

Lorem ipsum dolor
£100bn
Lorem ipsum dolor
£500bn
Lorem ipsum dolor
£1trn

How we innovate

Vaccines delivered in 2021
>767m
Medicine doses delivered in 2021
1.7bn

Innovation

Vaccines delivered in 2021
>767m

Cards - Filterable

Filter by0.1:

All Events0.1
Dividend
Quarterly Results

2022

5
July

Dividend

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

2
Jun

Quarterly Results

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

2023

5
Feb

Label

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

20
Sep

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

10
Oct

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

11
Nov

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

Key dates

04
Oct

Label

Emma Walmsley, CEO, will present at the BofA Global Healthcare Conference on Friday 16 September. The webcast replay will be available within 24 hours after conclusion of live event.

Company

09
Sept

Date

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut et nulla rhoncus, pellentesque ante at, cursus tortor. Nunc rhoncus pulvinar tincidunt.

Products

05
Nov

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut et nulla rhoncus, pellentesque ante at, cursus tortor. Nunc rhoncus pulvinar tincidunt.

04
Dec

Label

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut et nulla rhoncus, pellentesque ante at, cursus tortor. Nunc rhoncus pulvinar tincidunt.

05
Jan

Label

Text

Company

Large cards 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent eu eros id sem dictum placerat in ac mauris. Morbi varius ultricies justo, non sodales neque finibus et. Donec at urna at velit posuere lacinia eu et tortor. Cras non purus leo. Duis sit amet ex non turpis dictum viverra. Nullam rhoncus ex vel nisl convallis, et facilisis sem scelerisque. Sed quis viverra nisi, a luctus massa. Aenean imperdiet venenatis velit nec pharetra. Ut quis lorem sed tellus dictum finibus. Mauris pharetra nunc in sollicitudin dignissim. Donec quis lorem consectetur, finibus tellus vitae, pretium enim. Nam elementum mattis arcu, eget imperdiet turpis mattis a.

Fusce ut aliquam nibh. Morbi ac nulla et diam aliquet ornare quis a quam. Donec ut nunc lobortis, porttitor erat sit amet, tempor erat. Phasellus urna dui, sollicitudin eu enim ac, fringilla viverra nisl. Proin hendrerit in erat vel egestas. Pellentesque id porttitor justo, viverra facilisis nulla. Ut lacinia sed eros nec mollis. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Interdum et malesuada fames ac ante ipsum primis in faucibus. In facilisis fermentum urna, eget maximus ligula dapibus ut. Nullam ut luctus ligula. Nunc elementum vehicula metus. Donec pharetra egestas risus eget iaculis. Nullam sed feugiat tellus. Donec ut ex sapien.

Large cards 2

Large Card 1

Large Card 2

Large card 3

Cards Hyperlinks

Sometimes back, I needed to count characters in a piece of content for use as an informational post

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In magna risus, feugiat in erat quis, matti

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean

Larger title going two lines

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In magna risus, feugiat in erat quis, matti

Just title

Small text

Hyperlink card

Description

Title

Lorem ipsum

Title

Description lorem ipsum

Header

At GSK, our pipeline is focused on unlocking the science of the immune system, human genetics and advanced technologies to develop innovative vaccines and specialty medicines.

Image

Media Image test

Broll

Media asset

Outstanding People

Video test

Label

Title

B1e4411895528d3e028825e28a73340d695bdd09

Label 2

Title 2

Vaccines

Vaccines help protect people from infectious diseases at every stage of life. Our vaccines portfolio is the broadest in the industry, helping protect people from meningitis, shingles, flu, polio, measles and many more. Today, two million doses of our vaccines are administered daily, and 4 in 10 of the world’s children receive a GSK jab each year. We use diverse platform technologies from adjuvants that improve vaccine effectiveness through to mRNA technology. These are at the heart of our pipeline differentiation.

Specialty medicines

Specialty medicines are prescribed by specialist healthcare practitioners. For GSK this includes our cancer medicines that have life-changing potential for patients. We’re also developing medicines for immune-mediated conditions, including the first new medicine for the chronic autoimmune condition lupus in over 50 years.

We are global leaders in developing medicines for HIV. Having pioneered the first HIV treatments in the 1980s, our goal now is to limit the impact of HIV on people’s lives by treating, preventing and ultimately curing it.

General medicines

General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. For us, this includes our inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Every day, these medicines improve health and make life better for millions of people all over the world. For more than 50 years, we’ve helped millions of people with respiratory conditions to breathe more easily, including the first inhalers in 1969, and we remain the industry leader in respiratory science.

Prioritising innovation in vaccines & specialty medicines

Almost half the vaccines and medicines in our pipeline address infectious diseases, helping protect people from diseases like meningitis, shingles, flu, polio, measles and many more. Almost half the vaccines and medicines in our pipeline address infectious diseases, helping protect people from diseases like meningitis, shingles, flu, polio, measles and many more.

HIV Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam augue metu

Our long-acting HIV medicines have the potential to dramatically change people’s experience by giving them an alternative to daily medicine.

Oncology

We develop cancer medicines with life-changing potential for patients with ovarian cancer, endometrial cancer and multiple myeloma. We’ve accelerated this research and currently have three marketed therapies and a further nine assets in development.

Immunology

Our focus on the science of the immune system helps us develop vaccines and medicines for a range of immune-mediated conditions, including the first new medicine for the chronic autoimmune condition lupus in over 50 years.

Flip card

Flip it

Cards - Pop up

Title 1

Description 1

Title 2

Description 2

Title 3

Description 3

Title 4

Description 4

Title 5

Description 5

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam neque eros, vehicula ac purus ac, pulvinar interdum mi. Mauris mollis elementum purus, ut dictum neque faucibus ut. Proin eget tortor euismod, volutpat arcu ac, lobortis nunc. Sed a libero tellus. Sed et lorem lobortis libero cursus faucibus.

23423

Text
234
234234
234

Title

text

hello

rte rte

Testing audio player

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

LISTEN NOW

Lorem ipsum dolor sit amet

29 February 2024
MP3 - 7.7MB

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.